ABSTRACT
Hospice and palliative care programs have grown rapidly in the United States over the last 25 years. Relief of suffering and maximization of quality of life including symptom control, psychosocial health, and spiritual care are the primary goals of hospice and palliative care. This article reviews the development, philosophy, and practice of hospice and palliative care, and describes barriers to and suggestions for integrating this approach into mainstream medicine.
Subject(s)
Hospice Care/organization & administration , Palliative Care/organization & administration , Attitude to Death , Family/psychology , Forecasting , Health Services Accessibility/organization & administration , Hospice Care/psychology , Humans , Models, Organizational , Needs Assessment , Organizational Objectives , Organizational Policy , Pain/etiology , Pain/prevention & control , Patient Acceptance of Health Care/statistics & numerical data , Patient Care Team/organization & administration , Philosophy, Medical , Prognosis , Quality of Life , United StatesABSTRACT
BACKGROUND: Pain affects more than 70% of cancer patients but is often undertreated. METHODS: The authors review and present methodologies to maximize proper palliative approaches to this symptom for the majority of patients. RESULTS: The World Health Organization's stepwise guide to pain control serves as an excellent basis for management. Around-the-clock dosing, using adjuvant treatments, and using noninvasive routes of administration provide good pain control for 80% of patients. CONCLUSIONS: Barriers to effective pain control will be reduced as new JCAHO standards regarding pain control are implemented.
Subject(s)
Analgesia/methods , Neoplasms/complications , Pain Measurement , Pain/drug therapy , Palliative Care , Aged , Biofeedback, Psychology , Humans , Lung Neoplasms/complications , Male , Pain/etiology , Pain/physiopathology , Practice Guidelines as Topic , Quality of Life , World Health OrganizationABSTRACT
Cutaneous malignancies are the most common cancers found in the primary care setting. It is imperative that all primary care providers become competent in evaluating skin lesions. Actinic keratoses are the most common premalignant lesions. These rough scaly plaques are the direct result of ultraviolet and other carcinogenic exposure. Actinic keratoses may be the first clinical sign to alert primary care practitioners of severe solar dermatitis and herald the development of skin cancer. Treatment is cryotherapy or topical chemotherapeutic agents such as 5-fluorouracil. Basal and squamous cell carcinomas are the most common nonmelanoma skin cancers. The primary cause is cumulative exposure to ultraviolet radiation from the sun, although other factors exist. Treatment is generally surgical excision performed by a practitioner skilled in this type of procedure contingent on tumor type, size, location, aggressiveness, and other factors. Other common treatments include electrodesiccation and curettage and cryotherapy. The incidence of malignant melanoma is the fastest rising cancer in the United States. Early detection and prevention are the mainstays of a good outcome. Depth of the lesion is the primary determinant in staging and prognosis, although other factors are also important. As the incidence of skin cancer increases, primary care practitioners play an integral role in the diagnosis, treatment, and prevention of skin cancer. The importance of early detection and appropriate referral by primary care providers will become even more crucial in the prognosis of afflicted patients.
Subject(s)
Precancerous Conditions/pathology , Skin Neoplasms , Diagnosis, Differential , Humans , Risk Factors , Skin Neoplasms/diagnosis , Skin Neoplasms/epidemiology , Skin Neoplasms/etiology , Skin Neoplasms/therapy , Sunlight/adverse effects , United States/epidemiologyABSTRACT
Recent events have challenged our health system to increase access to and provide high quality care for patients near the end of life. Simultaneously, Medicare is developing review policies to determine eligibility for hospice patients with select noncancer diagnoses. The purpose of this study was to determine whether the proposed policies met one of their chief goals: accurate identification of patients with a less-than-six-months prognosis. Only 35 percent of 104 patients who died within six months of admission to the hospice used for this study, LifePath Hospice, met the Medicare proposed criteria for hospice eligibility. The median and mean survival time of the sample was 14 and 30 days respectively. Based on this review, it is recommended that Medicare alter their proposed review policies and not limit access to hospice eligible patients who desire and are in need of such services.